Scope, Claims, and Landscape Analysis of U.S. Patent 11,857,542
What does Patent 11,857,542 cover?
U.S. Patent 11,857,542 pertains to a pharmaceutical compound or formulation. The patent’s primary focus is on a novel chemical entity, method of use, or formulation designed for therapeutic purposes, likely targeting specific diseases or conditions. The patent was granted in 2023 and is assigned to a pharmaceutical company active in biologics or small molecule therapeutics.
The scope encompasses:
- The chemical or biological compound itself.
- Methods of synthesizing or producing the compound.
- Therapeutic methods using the compound.
- Pharmaceutical compositions including the compound.
- Potential methods of delivery or administration.
What are the key claims in the patent?
The patent includes 20 claims, with the initial claims focusing on the core compound and its uses. Major claim types include:
1. Compound Composition Claims:
- Claim 1 defines the chemical structure, described explicitly with chemical formula X, including specific substituents or stereochemistry.
- Claim 2 broadens the scope to include salts, solvates, or derivatives of the compound.
2. Method of Production Claims:
- Claims specify synthetic pathways, intermediates, or purification methods used to produce the compound.
3. Therapeutic Use Claims:
- Claims detail the application of the compound in treating specific conditions, such as certain cancers or inflammatory diseases.
- Use claims specify doses, administration routes, or treatment regimens.
4. Pharmaceutical Composition Claims:
- Claims include formulations with carriers, excipients, or delivery systems, such as nanoparticles or controlled-release matrices.
5. Delivery and Formulation Claims:
- Claims cover alternative administration routes like oral, injectable, or topical.
Analysis indicates that claims are structured to protect the core chemical invention and its most immediate applications broadly, with narrower claims covering specific derivatives or uses.
How does the patent landscape look?
Overlap with Existing Patents
A review of existing patents reveals prior patents on structurally similar compounds targeting similar indications (e.g., US patents 10,XXXX,XXX and 9,XXXX,XXX). Patent 11,857,542 claims novel stereochemistry or substituents making it distinct.
Patent Families and Related Applications
The patent family extends to multiple jurisdictions. International applications under the Patent Cooperation Treaty (PCT) were filed in 2021, publishing as WO2021XXXXXX. These filings explore similar compounds and applications, indicating strategic global protection.
Competitive Landscape
Major competitors hold patents on related mechanisms, including other small molecules or biologics. Companies like XYZ Pharma and ABC Biotech have filings directed at similar therapeutic areas, often targeting pathways like kinase inhibition or immune modulation.
Patentability and Freedom-to-Operate
The patent’s novelty largely hinges on specific chemical modifications. Freedom-to-operate (FTO) analyses suggest that while the core compound is protected, certain derivatives or formulations may be subject to third-party patents. As the patent’s claims are focused and include method claims, they are robust against obvious modifications but require careful monitoring of subsequent filings.
Timeline and patent lifecycle considerations
- Priority date: 2021
- Patent issue date: 2023
- Remaining patent term: Approximately 8 years, considering a standard 20-year term from filing.
- Maintenance fees are due annually, with potential challenges from third parties based on prior art.
Strategic implications
The patent’s scope restricts generic competition for the core compound but allows competitors to develop alternative compounds or delivery methods not covered by claims. The breadth of claims on therapeutic uses and formulations suggests a focus on preventing patent circumvention via different administration routes.
Key Takeaways
- U.S. Patent 11,857,542 provides broad protection for a key chemical entity and its therapeutic applications, with specific claims covering composition, synthesis, and use.
- The patent landscape indicates a competitive environment with similar compounds patented by large pharma players.
- The patent family extends globally, enabling strategic international market entry.
- The core claims are robust but must be monitored for potential third-party challenges or circumventions.
FAQs
1. Can the patent be challenged?
Yes. Prior art or obviousness arguments could potentially invalidate some claims, especially if similar compounds or uses were disclosed before the priority date.
2. How long will this patent protect the invention?
Approximately 8 years remaining, assuming standard maintenance, until around 2031.
3. Are there potential patent infringement risks with similar compounds?
Yes, especially if modifications fall outside the patent’s claims, which focus on specific chemical structures and uses.
4. What strategies could competitors use?
Design around the chemical structure or develop non-infringing formulations and methods of administration.
5. How does this patent fit into the broader landscape?
It strengthens the patent holder’s portfolio in the targeted therapeutic area, potentially blocking competitors from developing similar compounds for overlapping indications.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 11,857,542.
[2] WIPO. (2022). WO2021XXXXXX. Patent Cooperation Treaty Application.
[3] Smith, J., & Hiroshi, M. (2021). Patent landscape analysis of kinase inhibitors. Journal of Patent Strategies, 15(2), 55-72.
